An MRDR paper investigating the presence of 1q21 gain and amplification on outcomes in Daratumumab-treated MM patients has now been published!
The recording of the meeting is now available to those who may have missed out!
See where and when MRDR presentations are happening in Blood 2024!
Please join us for breakfast at the MRDR Annual Breakfast Meeting at Blood 2024, 28th October
An MRDR paper on the development and validation of a discrete-event simulation model of MM disease outcomes has now been published!
An MRDR paper investigating variation in immunoglobulin use and survival in myeloma has now been published!
The MRDR reaches another milestone of recruiting more than 7,000 patients!
_ENGLISH.png)